Ascendis Pharma A/S vs Paycom Software Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Paycom Software Inc trades at $211 (market cap $9.57B). The key difference: Ascendis Pharma A/S is the larger of the two by market cap, and Paycom Software Inc pays a 0.71% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | PAYC | |
|---|---|---|
Market Cap | $16.67B | $9.57B |
Sector | Health | Technology |
52-Week High | $277.18 | $233.89 |
52-Week Low | $189.74 | $113.59 |
Enterprise Value | $17.04B | $10.35B |
Dividend Yield | — | 0.71% |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →